LUGANO, Switzerland, February 11 /PRNewswire/ Helsinn Healthcare SA, a Swiss pharmaceutical group, is pleased to announce, ahead of schedule, today s launch in the UK of Aloxi(R) (Palonosetron hydrochloride), a new generation treatment for chemotherapy, induced nausea and vomiting, by its local partner Maelor plc, the specialist hospital medicin